1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

        <em id="8sgz1"><label id="8sgz1"></label></em>
      2. <em id="8sgz1"><label id="8sgz1"></label></em>
        <em id="8sgz1"></em>
        <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

        <button id="8sgz1"></button>
        west china medical publishers
        Author
        • Title
        • Author
        • Keyword
        • Abstract
        Advance search
        Advance search

        Search

        find Author "LAM Wai Ching" 3 results
        • Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement

          草藥產品被廣泛使用,其成分及質量差異很大,在隨機對照試驗(randomized controlled trials,RCTs)中也十分常見。筆者基于 22 項 CONSORT 條目清單,對含草藥干預措施 RCTs 的報告內容提出推薦條目。經過電話溝通,筆者于加拿大多倫多與 16 位專家進行了專家共識會議。工作組通過了 9 項草藥 RCTs 的 CONSORT 清單條目,其中針對草藥干預措施的條目 4 闡述最為詳盡。這些推薦將會用于改善草藥干預措施 RCTs 的報告。

          Release date:2021-02-05 02:57 Export PDF Favorites Scan
        • Promoting data sharing in clinical trials to improve the transparency of clinical trials

          Sharing clinical trial data can increase the transparency of clinical trials and improve the its authenticity. The current requirements of clinical research data transparency is not fully adequate, and it is still difficult to create an environment in which the sharing of the clinical trial data becomes the norm. The article analyzed various concerns on data sharing and proposed solutions in data ownership, technology, implementation, and legal issues systematically, calling for clinical trial data sharing in order to promote transparency of clinical trials, and looking forward to minimize the risks and maximize the benefits of data sharing.

          Release date:2018-09-12 03:22 Export PDF Favorites Scan
        • Recommendations for reporting randomized controlled trials of herbal interventions: explanation and elaboration

          在臨床干預試驗中,運用隨機分配是對照試驗中控制偏倚和混雜的最佳工具。研究人員必須確保在試驗報告中包含讀者所需要的信息,以判斷結果的有效性及其意義。事實上,完整的試驗報告可讓臨床醫生改進他們的臨床實踐,以反映當前最佳證據,并改善患者臨床終點。制定 CONSORT 聲明可協助研究人員、作者、審稿人及編輯了解臨床試驗報告中所需的必要信息。CONSORT 聲明適用于任何干預措施,包括草藥產品。當前草藥干預措施的對照試驗未充分報告 CONSORT 建議的信息條目。我們希望最近制定的 CONSORT 建議條目擴展版能更準確地報告草藥干預措施隨機對照試驗,使其更加完整。我們編寫的這份解釋性文件除概述了每項建議的理由外,還提供了 CONSORT 條目和相關詳細說明,并為每項建議提供了良好報告和經驗證據的范例,以幫助作者能更好地運用它們。隨著越來越多的證據積累和反饋意見的收集,這些有關草藥產品臨床試驗報告的建議可隨時進行修訂。

          Release date:2021-02-05 02:57 Export PDF Favorites Scan
        1 pages Previous 1 Next

        Format

        Content

          1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

            <em id="8sgz1"><label id="8sgz1"></label></em>
          2. <em id="8sgz1"><label id="8sgz1"></label></em>
            <em id="8sgz1"></em>
            <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

            <button id="8sgz1"></button>
            欧美人与性动交α欧美精品